9 METERS BIOPHARMA INC (NMTR) Forecast, Price Target & Analyst Ratings

NASDAQ:NMTR • US6544052086

Current stock price

0.0722 USD
-0.05 (-42.97%)
At close:
0.093 USD
+0.02 (+28.81%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for 9 METERS BIOPHARMA INC (NMTR).

Forecast Snapshot

Consensus Price Target

Price Target
$10.58
+ 14,557.20% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Aug 14, 2023
Period
Q2 / 2023
EPS Estimate
-$0.59
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$10.58
Upside
+ 14,557.20%
From current price of $0.07 to mean target of $10.58, Based on 11 analyst forecasts
Low
$0.76
Median
$10.58
High
$21.00

Price Target Revisions

1 Month
0.00%
3 Months
-49.55%

Price Target Summary

11 Wall Street analysts provided a forecast for the next 12 months for NMTR. The average price target is 10.58 USD. This implies a price increase of 14557.2% is expected in the next year compared to the current price of 0.0722.
The average price target has been revised downward by 49.55% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

NMTR Current Analyst RatingNMTR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

NMTR Historical Analyst RatingsNMTR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
NMTR was analyzed by 11 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about NMTR.
In the previous month the buy percentage consensus was at a similar level.
NMTR was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-05-18CitigroupMaintains Neutral -> Neutral
2023-03-20Truist SecuritiesDowngrade Buy -> Hold
2023-02-13CitigroupInitiate Neutral
2022-11-10BMO CapitalMaintains Outperform
2022-09-27OppenheimerMaintains Outperform
2022-07-01Maxim GroupDowngrade Buy -> Hold
2022-06-22BMO CapitalMaintains Outperform
2022-06-22Truist SecuritiesMaintains Buy
2021-07-08BMO CapitalInitiate Outperform
2021-06-04CitigroupInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Aug 14, 2023
Period
Q2 / 2023
EPS Estimate
-$0.59
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
26.66%
Number of Analysts
7

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
6.93%

Next Earnings Summary

NMTR is expected to report earnings on 8/14/2023. The consensus EPS estimate for the next earnings is -0.59 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
NMTR revenue by date.NMTR revenue by date.
8.27M4.07M
-50.79%		1.88M
-53.81%		N/A
-100.00%		N/A6.375M
-100.00%		37.09M110.89M
198.98%		207.01M
86.68%		337.18M
62.88%		445.15M
32.02%
EBITDA
YoY % growth
NMTR ebitda by date.NMTR ebitda by date.
-6.41M-5.82M
9.20%		-6.53M
-12.20%		N/A
-178.71%		N/A
-40.27%		-63.852M
-11.99%		-37.74M
-10.71%		-38.421M
-32.73%		-14.708M
64.99%		-28.835M
-96.05%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
NMTR ebit by date.NMTR ebit by date.
-6.46M-5.95M
7.89%		-6.66M
-11.93%		N/A
-173.57%		N/A
-40.23%		-48.781M
-11.98%		-36.59M
-10.65%		-41.43M
-32.72%		-39.075M
7.00%		-53.221M
-36.20%		-44.51M
16.37%		-27.12M
39.07%		25.059M
192.40%		92.548M
269.32%		178.73M
93.12%		254.78M
42.55%
Operating Margin
NMTR operating margin by date.NMTR operating margin by date.
-78.11%-146.19%-354.26%N/AN/AN/AN/AN/A-612.95%N/AN/A-73.12%22.60%44.71%53.01%57.23%
EPS
YoY % growth
NMTR eps by date.NMTR eps by date.
N/AN/AN/AN/AN/A
-106.32%		-11.63
71.94%		-3.09
-2,627.27%		-3.29
-8.00%		-1.35
58.27%		-1.25
7.20%		-1.11
11.87%		4.71
526.20%		7.02
48.92%		7.38
5.23%		8.65
17.13%		9.93
14.86%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 23 Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.59
26.66%		-0.41
43.33%		-0.57
38.19%		-1.14
-12.00%		-1.14
-94.71%		-1.17
-187.50%		-1.13
-99.10%		-1.03
9.82%		-1.04
8.93%		-1.35
-14.78%		-1.18
-4.50%
Revenue
Q2Q % growth		N/AN/AN/A2.372M
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-9.618M
14.09%		-9.749M
-11.85%		-8.677M
19.22%		N/AN/AN/AN/AN/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

NMTR Yearly Revenue VS EstimatesNMTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2023 2026 2027 2028 2029 2030 100M 200M 300M 400M
NMTR Yearly EPS VS EstimatesNMTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 5 -5 -10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
18.37%
EPS Next 5 Year
33.03%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

9 METERS BIOPHARMA INC / NMTR Forecast FAQ

What is the average price target for 9 METERS BIOPHARMA INC (NMTR) stock?

11 analysts have analysed NMTR and the average price target is 10.58 USD. This implies a price increase of 14557.2% is expected in the next year compared to the current price of 0.0722.

When does 9 METERS BIOPHARMA INC (NMTR) report earnings?

9 METERS BIOPHARMA INC (NMTR) will report earnings on 2023-08-14, before the market open.

Can you provide the consensus estimates for 9 METERS BIOPHARMA INC next earnings?

The consensus EPS estimate for the next earnings of 9 METERS BIOPHARMA INC (NMTR) is -0.59 USD and the consensus revenue estimate is 0 USD.

How do analysts rate 9 METERS BIOPHARMA INC (NMTR)?

The consensus rating for 9 METERS BIOPHARMA INC (NMTR) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.